NCT04604613View on ClinicalTrials.gov

Prediction of Recurrence Among Low Risk Endometrial Cancer Patients

Active, not recruitingOBSERVATIONAL
Enrollment

518

Participants

Timeline

Start Date

November 8, 2012

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
FIGO Grade 1 Endometrial Endometrioid AdenocarcinomaFIGO Grade 2 Endometrial Endometrioid Adenocarcinoma
Interventions
PROCEDURE

Bilateral Salpingectomy with Oophorectomy

Undergo standard of care bilateral salpingo-oophorectomy

PROCEDURE

Biospecimen Collection

Undergo collection of blood and tissue samples

PROCEDURE

Hysterectomy

Undergo standard of care hysterectomy

OTHER

Laboratory Biomarker Analysis

Correlative studies

PROCEDURE

Lymph Node Mapping

Undergo sentinel lymph node mapping

PROCEDURE

Sentinel Lymph Node Biopsy

Undergo sentinel lymph node biopsy

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT04604613 - Prediction of Recurrence Among Low Risk Endometrial Cancer Patients | Biotech Hunter | Biotech Hunter